Al-Moudawi welcomes new opportunities. We are committed to being the first choice for pharmaceutical and aesthetic companies in the Iraqi market.
Contact us now by clicking the button below, or send us an email at [email protected]
Al Moudawi pharmaceuticals was founded in 2013 with the synergy of two groups that have more than 50 years experience in the medical and pharmaceutical fields.The expertise in the medical and OTC promotion along with the knowledge of the Iraqi market and its dynamics brought these two groups together to create a company that guarantees internationally recognized quality.Our Mission is to ensure the availability of high-quality branded pharmaceuticals and medical aesthetics to those who need it across Iraq at the right place and at the right time.
Al Moudawi is thrilled to announce that it has achieved the prestigious ISO 9001 certification. Committed to delivering top-notch services, this certification reflects our unwavering dedication to quality, efficiency, and customer satisfaction.
AlMoudawi Pharmaceutical is proud to announce that it has successfully obtained the Good Distribution Practice (GDP) certification. This significant milestone underscores our unwavering commitment to delivering safe, high-quality medicines to patients worldwide.The GDP certification is a testament to AlMoudawi Pharmaceutical's adherence to the strictest international standards for the distribution of pharmaceutical products. It validates our robust quality management systems, efficient supply chain operations, and dedicated team of professionals.
A diversified portfolio of internationaly trusted brands
A portfolio of premium-quality, and world-renowned brands
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our product line includes BOTOX® Cosmetic (onabotulinumtoxinA) and JUVÉDERM® Collection of Fillers. With our own research and development team focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available.
We are an international company based in Parma, with more 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.Its R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham and Oxford (UK) and Lidingö (Sweden) part of the acquisition of protein therapeutics biotech Zymenex in 2013. We export to more than 80 countries with a direct presence in 28.The Chiesi Group employs approximately 5,624 people, 788 of whom are dedicated to R&D activities and 827 of whom work at production sites in Italy, France and Brazil.
The Menarini Group is the leading Italian pharmaceutical company in the world, a guarantee of internationally recognised quality. The achieved results are proof of an efficient strategy based on Research, Innovation and Internationalisation, along with the ability to recognize and meet the needs of physicians and patients alike.One of the Menarini Group's strong points is its collaboration with international partners: the goal is to create synergies that give rise to cutting-edge solutions, pharmaceutical products, and services in the health sector.
Al Moudawi engages in numerous operations to ensure its commitment to its stakeholders:
Read More